Royal Brompton & Harefield NHS Foundation Trust
🇬🇧United Kingdom
Rosiglitazone Plaque Study
Phase 3
- Conditions
- Diabetes Mellitus, Type 2Vascular DiseasesHypertension
- First Posted Date
- 2005-07-22
- Last Posted Date
- 2005-08-01
- Lead Sponsor
- Royal Brompton & Harefield NHS Foundation Trust
- Target Recruit Count
- 60
- Registration Number
- NCT00123227
- Locations
- 🇬🇧
Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, United Kingdom
🇬🇧St Mary's NHS Trust, London, United Kingdom
Combined Chelation Treatment With Deferiprone and Deferoxamine in Thalassemia Major
Phase 4
- Conditions
- Beta-Thalassemia
- First Posted Date
- 2005-02-15
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Royal Brompton & Harefield NHS Foundation Trust
- Target Recruit Count
- 65
- Registration Number
- NCT00103753
- Locations
- 🇮🇹
Ospedale Microcitemico, Via Jenner, Cagliari, Sardinia, Italy